ID: ALA4244395

Max Phase: Preclinical

Molecular Formula: C12H8O5

Molecular Weight: 232.19

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=Cc1ccc(-c2ccc(C(=O)O)c(O)c2)o1

Standard InChI:  InChI=1S/C12H8O5/c13-6-8-2-4-11(17-8)7-1-3-9(12(15)16)10(14)5-7/h1-6,14H,(H,15,16)

Standard InChI Key:  BKNVVYRQMKQLFC-UHFFFAOYSA-N

Associated Targets(non-human)

Hydroxyacid oxidase 1 172 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 232.19Molecular Weight (Monoisotopic): 232.0372AlogP: 2.16#Rotatable Bonds: 3
Polar Surface Area: 87.74Molecular Species: ACIDHBA: 4HBD: 2
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 2.61CX Basic pKa: CX LogP: 2.32CX LogD: -1.19
Aromatic Rings: 2Heavy Atoms: 17QED Weighted: 0.79Np Likeness Score: 0.11

References

1. Moya-Garzón MD, Martín Higueras C, Peñalver P, Romera M, Fernandes MX, Franco-Montalbán F, Gómez-Vidal JA, Salido E, Díaz-Gavilán M..  (2018)  Salicylic Acid Derivatives Inhibit Oxalate Production in Mouse Hepatocytes with Primary Hyperoxaluria Type 1.,  61  (16): [PMID:30028141] [10.1021/acs.jmedchem.8b00399]

Source